Surgical Management of the Axilla of HER2+ Breast Cancer in the Z1071 Era: A Propensity-Score-Matched Analysis of the NCDB.

Samer A NaffoujeArvind SabesanSusan J HooverMarie C LeeChristine Laronga

Published in: Annals of surgical oncology (2021)

In cN1 HER2+ IDC patients who demonstrate cCR to NAST, SLNB is a reasonable definitive procedure for axillary management with comparable OS outcomes to ALND. However, higher-level data are required to determine the appropriate management in the case of ypN+.

Keyphrases

sentinel lymph node
lymph node
minimally invasive
neoadjuvant chemotherapy
regulatory t cells
immune response
radiation therapy
early stage
adipose tissue
machine learning
skeletal muscle
artificial intelligence
weight loss
glycemic control